Publication
Title
Immune cells enhance selectivity of nanosecond-pulsed DBD plasma against tumor cells
Author
Abstract
Cancer immunotherapy is a promising strategy that engages the patient's immune system to kill cancer cells selectively while sparing normal tissue. Treatment of macrophages with a nanosecond-pulsed dielectric barrier discharge directly enhanced their cytotoxic activity against tumor cells but not normal cells. These results underscore the clinical potential of plasma for cancer immunotherapy.
Language
English
Source (journal)
Plasma medicine
Publication
2017
Volume/pages
7:1(2017), p. 85-96
Full text (Publisher's DOI)
Full text (publisher's version - intranet only)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Record
Identification
Creation 12.12.2018
Last edited 15.07.2021
To cite this reference